Clinical Trials Sponsored by Reliant Pharmaceuticals
Total 19613 results
-
Navitor Pharmaceuticals, Inc.Supernus Pharmaceuticals, Inc.Completed
-
Ferring PharmaceuticalsFerring Pharmaceuticals Korea, Ltd.CompletedProstate CancerKorea, Republic of
-
Universidade Federal FluminenseEliane dos Santos Porto Barboza; Diogo Luz; Denise MandarinoUnknown
-
Neurotech PharmaceuticalsNot yet recruitingMacular Telangiectasia Type 2United States
-
Regeneron PharmaceuticalsNot yet recruiting
-
Regeneron PharmaceuticalsRecruiting
-
Arrowhead PharmaceuticalsRecruitingSevere HypertriglyceridemiaUnited States
-
Acumen PharmaceuticalsRecruitingAlzheimer DiseaseUnited States, France, Italy, Germany, Spain, Canada, Poland, United Kingdom
-
Gilgamesh PharmaceuticalsRecruitingMajor Depressive DisorderUnited Kingdom
-
Ferring PharmaceuticalsRecruitingInflammatory Gastrointestinal DiseasesGermany
-
Novilla PharmaceuticalsNot yet recruitingAcute Pain | Gout Flare | Acute Gouty ArthritisAustralia
-
Dizal PharmaceuticalsRecruitingNon-small Cell Lung CancerChina
-
Alnylam PharmaceuticalsRecruitingHypertension | High Cardiovascular RiskUnited States
-
Ferring PharmaceuticalsRecruiting
-
Gilgamesh PharmaceuticalsRecruitingMajor Depressive DisorderUnited Kingdom
-
Regeneron PharmaceuticalsRecruitingRelapsed/Refractory Follicular Lymphoma | Marginal Zone Lymphoma (MZL)Korea, Republic of, Australia, Spain, Malaysia, France, Taiwan, Italy, Poland, United States, Thailand, United Kingdom, Turkey, Belgium, Czechia
-
Regeneron PharmaceuticalsRecruiting
-
Currax PharmaceuticalsRecruiting
-
SciClone PharmaceuticalsNot yet recruiting
-
Regeneron PharmaceuticalsRecruitingCongenital Hearing Loss Secondary to Biallelic Mutations in the Otoferlin Gene (OTOF) | Biallelic Mutations in the Gap Junction Beta 2 (GJB2) Gene | Digenic Mutations in GJB2/Gap Junction Beta 6 (GJB6) GenesUnited States
-
Regeneron PharmaceuticalsNot yet recruitingDiabetic Macular Edema (DME) | Neovascular Age-Related Macular Degeneration (nAMD)
-
Vanda PharmaceuticalsRecruitingMotion SicknessUnited States
-
MinaPharm PharmaceuticalsRecruitingSurgical Site InfectionsEgypt
-
Jazz PharmaceuticalsRecruitingTuberous Sclerosis Complex Associated Neuropsychiatric DiseaseUnited States, United Kingdom, Poland
-
Ferring PharmaceuticalsRecruitingClostridium Difficile Infection RecurrenceUnited States
-
Quoin PharmaceuticalsRecruitingNetherton SyndromeUnited States
-
Alnylam PharmaceuticalsRecruitingType 2 Diabetes Mellitus (T2DM)Canada, United States
-
CStone PharmaceuticalsNot yet recruitingExtranodal NK/T-cell Lymphoma
-
ASLAN PharmaceuticalsRecruitingAtopic DermatitisUnited States, Canada
-
Regeneron PharmaceuticalsRecruitingB-cell Non-Hodgkins Lymphoma (B-NHL)United States, United Kingdom
-
Vanda PharmaceuticalsRecruitingSchizophrenia | Bipolar I DisorderUnited States
-
Jazz PharmaceuticalsRecruitingParkinson Disease | TremorUnited States, Spain, Germany, Poland
-
Regeneron PharmaceuticalsRecruiting
-
Jazz PharmaceuticalsRecruitingSolid Tumor | Metastatic Cancer | Advanced CancerUnited States
-
Regeneron PharmaceuticalsRecruitingNon-alcoholic Steatohepatitis (NASH) | Metabolic Dysfunction Associated Steatohepatitis (MASH)United States, Korea, Republic of, Puerto Rico, Japan
-
Sparrow PharmaceuticalsRecruitingPolymyalgia RheumaticaGermany
-
Sparrow PharmaceuticalsRecruitingAutonomous Cortisol Secretion (ACS) | ACTH-Independent Cushing Syndrome | ACTH-Independent Adrenal Cushing Syndrome, SomaticUnited States, United Kingdom, France, Romania
-
ORIC PharmaceuticalsRecruitingMetastatic Prostate Cancer | Neuroendocrine Prostate CancerUnited States
-
CStone PharmaceuticalsRecruitingGastrointestinal Stromal TumorsChina
-
Regeneron PharmaceuticalsRegeneron PharmaceuticalsRecruitingNon-small Cell Lung CancerGermany, Austria, France
-
Regeneron PharmaceuticalsRecruitingMelanomaUnited States, Spain, Germany, Mexico, Turkey, Canada, Austria, Netherlands, United Kingdom, Italy, Georgia, France, Brazil, Romania, Czechia, Argentina, Australia, Ireland, Chile, Hungary, South Africa, Belgium, Poland, Peru
-
ORIC PharmaceuticalsRecruitingPh 1/2 Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 AlterationSolid TumorsKorea, Republic of, United States, Australia, Canada
-
Arrowhead PharmaceuticalsRecruitingChronic Obstructive Pulmonary Disease | AsthmaKorea, Republic of, Australia, New Zealand, Poland, Thailand, Spain
-
CStone PharmaceuticalsRecruitingAdvanced Solid Tumor | Advanced LymphomaChina, Australia, United States
-
Ferring PharmaceuticalsRecruitingInfertilityItaly, Spain, France, United Kingdom, Austria
-
Alnylam PharmaceuticalsRecruitingEarly-Onset Alzheimer DiseaseUnited Kingdom, United States, Netherlands, Canada
-
EOM PharmaceuticalsRecruitingCOVID-19 Pneumonia | COVID-19 Respiratory Infection | COVID-19 Acute Respiratory Distress SyndromeBrazil
-
Regeneron PharmaceuticalsRecruitingParoxysmal Nocturnal HemoglobinuriaMexico, Korea, Republic of, Turkey, Italy, United Kingdom, Thailand, Poland, Singapore, Spain, Taiwan, Canada, Japan, United States, Malaysia, Greece, Romania, Hungary
-
Jazz PharmaceuticalsRecruitingTuberous Sclerosis Complex | Dravet Syndrome | Lennox Gastaut SyndromeUnited States
-
Eledon PharmaceuticalsRecruitingKidney TransplantCanada, Australia, United Kingdom